Radiotherapy and chemotherapy cycles after breast cancer surgery

A comprehensive treatment model for breast cancer with surgery as the core. After surgery, the patient's condition is evaluated based on the pathological diagnosis to determine whether postoperative radiotherapy and chemotherapy are needed. If postoperative chemotherapy is required, a chemotherapy plan needs to be formulated based on the patient's condition, generally for 6-8 cycles of 21 days each. Radiotherapy after adjuvant chemotherapy, the cycle is generally 5 weeks, 2Gy each time, 1 irradiation five times a week, that is, 50Gy, this dose is a preventive dose, which means that the patient has undergone surgical treatment and chemotherapy before radiotherapy and has no solid tumor lesions.

The role of chemotherapy after breast cancer surgery

The role of chemotherapy for breast cancer is mainly to control potential systemic lesions. It belongs to systemic treatment and can control early potential metastatic lesions. There is no clear imaging method for this kind of metastasis in clinical practice. At this time, chemotherapy has a significant effect on controlling potential lesions. The role of postoperative radiotherapy is mainly on local tumors and chest wall, with the focus on preventing local recurrence. The main role of postoperative chemotherapy is to prevent cancer metastasis. Whether the patient needs postoperative chemotherapy should be determined based on the pathological diagnosis and after expert judgment.

How long does it take to get chemotherapy after breast cancer surgery?

After breast cancer surgery, radiotherapy, chemotherapy, etc. should be supplemented according to the tumor stage and the patient's physical condition. Chemotherapy is a treatment method that uses anticancer drugs to inhibit cancer cell division and destroy cancer cells. It is referred to as chemotherapy. The best time for chemotherapy is 2-3 weeks after surgery. Commonly used drugs include doxorubicin, cyclophosphamide, fluorouracil, paclitaxel, docetaxel, gemcitabine, etc. Chemotherapy can reduce the risk of cancer recurrence or metastasis, but it cannot eradicate it. Please combine the specific medication with clinical practice and follow the doctor's face-to-face guidance.